Healthcare
Istios Health Expands Clinical Research Network into Texas Through Kidney Care Associates Partnership
Istios Health Expands Clinical Research Network into Texas Through Kidney Care Associates Partnership
Oct 22 · 10:00GlobeNewswire
Istios Health Expands Clinical Research Network into Texas Through Kidney Care Associates Partnership
PURCHASE, N.Y., Oct. 22, 2026 -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, has aligned with the U.S. Food and Drug Administration (FDA) on key elements of a Phase 3 study in dementia with Lewy bodies (DLB) including patient selection, dose, duration, and endpoints. The planned registrational study is expected to enroll participants with mild-to-moderate DLB who will be randomized to receive either 100 mg of once-daily oral zervimesine or placebo for nine months.
Women in Finance Want Equal Recognition: Drofa Comms Responds With Women Leading the Way Digital Magazine 2026
TTM Technologies, Inc. Reports Third Quarter 2026 Results
Vitaquest names Martin Gargiule CFO, adding 25+ years of consumer health, pharma, and manufacturing finance expertise to its growing leadership team.
Mullen Group Ltd. Internal Growth Drives Record Quarterly Financial Results
LOUISVILLE, Colo., Oct. 22, 2026 -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the third quarter ended September 30, 2026 after the close of trading on Thursday, November 5. Biodesix management will host a conference call and webcast to discuss its financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.
FORT WORTH, Texas, Oct. 22, 2026 -- FirstCash Holdings, Inc. (“FirstCash” or the “Company”) (Nasdaq: FCFS), the leading international operator of more than 3,300 retail pawn stores, today announced record revenue and earnings results for the three and nine month periods ended September 30, 2026. The Company also announced that the Board of Directors declared a quarterly cash dividend of $0.46 per share, an increase of 10% over the previous quarterly dividend, which will be paid in November 2026. In addition, during the third quarter of 2026, the Company repurchased $123 million of common stock, bringing the total year-to-date share repurchases to $250 million.
0.42 g/t Au over 62.5 metres in LBP1341A 0.36 g/t Au over 144.8 metres in LBP1347 0.30 g/t Au over 91.4 metres in LBP1293
Suominen Corporation will publish its Interim report for January 1 – September 30, 2026, on Thursday, November 5, 2026, at approximately 9:00 a.m. (EET).
Harvia Plc press release 22 October 2026 at 1:00 p.m. EEST
KBR will support the revamp of two ammonia plants utilizing the company's industry-leading ammonia technology and proven revamp capabilities.